India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’

Case filed in 2022 by patient unable to afford medicine leads to cap on drug prices for millions who face ruin if diagnosed The Indian government has moved to reduce the price of cancer drugs after a retired bank clerk took her case to the supreme court. From next month, 137 cancer drugs in India will be cheaper as the government tries to tackle the tragedy of poorer patients either forgoing treatment, selling land or falling into debt to meet the high cost of some medicines, which are making large profits for hospitals and pharmacists. Continue reading...

印度最高法院在一位乳腺癌患者提起的诉讼中发现抗癌药流通环节加价率平均达170%，政府随后对137种抗癌药实施30%的加价上限。报道同时呈现了印度低收入家庭因药价放弃治疗、因病致贫的现实，以及民间对医疗体系整体改革的呼吁。